Publication date: December 2026 Source: Cytotherapy, Volume 28, Issue 12 Author(s): Michel Hauser, Alexander Reichenbach, Andreas Marti, Elise Drouyer, Emile Eichenlaub, François Pinsard, Franziska Isler, Iris Schmitt, Julia Djonova, Katharina Roten, Kira Blankenbach, Nina Ruef, Petra Kempná Bukovac, Petra Minder, Regula Johner, Susanne Wings, Thomas Schochat
Swissmedic Innovation Office: early regulatory engagement to accelerate ATMP clinical development—regulatory insights and recommendations. // Cytotherapy. – URL: https://www.sciencedirect.com/science/article/pii/S1465324926009187?dgcid=rss_sd_all
Swissmedic Innovation Office: early regulatory engagement to accelerate ATMP clinical development—regulatory insights and recommendations. Cytotherapy. https://www.sciencedirect.com/science/article/pii/S1465324926009187?dgcid=rss_sd_all
“Swissmedic Innovation Office: early regulatory engagement to accelerate ATMP clinical development—regulatory insights and recommendations.” Cytotherapy.
@article{article42953,
title = {Swissmedic Innovation Office: early regulatory engagement to accelerate ATMP clinical development—regulatory insights and recommendations},
journal = {Cytotherapy},
url = {https://www.sciencedirect.com/science/article/pii/S1465324926009187?dgcid=rss_sd_all}
}